Our 2025 Medicare Advantage competitive enrollment report analyzes decelerating growth as the market undergoes a period of correction. We discuss six key trends and action items for health plans.
Amid regulatory uncertainty, Medicare Advantage leaders’ priorities reveal a focus on weathering recent disruption, with an eye toward a more favorable forecast for the coming year.
Substance use disorder (SUD) platforms that provide care across the continuum can have tremendous impact. We discuss three essential goals and the related areas on which SUD providers need to focus.
Funding reports demonstrate the resilience and adaptability of digital health and suggest new venture patterns. But the sector will need to closely monitor and adapt to evolving regulations.
The growing need for lower-cost care and patient preferences are fueling greater ambulatory surgery center demand. We discuss the trend and what healthcare organizations should consider.
While a global, scalable solution for risk-based contracting in cancer has not yet emerged, we believe the sector will continue to evolve on a path toward value.
With the last funding allocation bills of 2024 signed into law, the White House is focusing on initiatives to support the healthcare system with the proposed 2025 budget.
The Medicare Advantage market is at an inflection point. In addition to increasing competition and slowing growth, revenue cuts and regulatory scrutiny may impact market opportunity.
